Immix Biopharma, Inc. Annual Interest Expense in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Immix Biopharma, Inc. annual/quarterly Interest Expense history and growth rate from 2020 to 2022.
  • Immix Biopharma, Inc. Interest Expense for the quarter ending June 30, 2022 was $109.000, a 99.8% decline year-over-year.
  • Immix Biopharma, Inc. Interest Expense for the twelve months ending June 30, 2022 was $98.9K.
  • Immix Biopharma, Inc. annual Interest Expense for 2022 was $497.000, a 99.7% decline from 2021.
  • Immix Biopharma, Inc. annual Interest Expense for 2021 was $180K, a 76.4% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $497 -$179K -99.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $180K +$77.9K +76.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $102K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.